Chinese investment firm Fosun International has announced a bid of €451m ($580m) to acquire Espirito Santo Saude (ESS), a Portugal-based hospital operator.

Offered through Fosun’s Portuguese subsidiary Fidelidade, the €4.72 per share beats the €4.50 per share bid made by Mexico’s Grupo Angeles.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Fosun noted that the bid represents a premium of 31% over the average share price from the previous six months.

"ESS operates hospitals, clinics and elderly care homes across Portugal."

ESS operates hospitals, clinics and elderly care homes across Portugal.

Portuguese healthcare firm Jose de Mello Saude has also submitted a €4.40 per share bid for the business.

See Also:

Fosun plans to acquire ESS to expand its private healthcare business in China, as the government intends to open the sector for private capital.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Espirito Santo group, which is a family owned network of companies with different businesses, has a 51% stake in ESS.

Currently, the group is under creditor protection, as it failed to meet debt payments.

In April, Fosun subsidiary Shanghai Fosun Pharmaceutical beat US buyout group Carlyl to win the bid to buy Chinese hospital chain Chindex, the Financial Times reported.